Nordic ListingsIssuer Report
NanoEcho AB: Quarterly Trading Report 2025 Q3
NanoEcho AB: Quarterly Trading Report 2025 Q3https://view.news.eu.nasdaq.com/view?id=b6fee0a394ffdc2f4787ae02084815fc4&lang=en&src=omxlink
NanoEcho AB: Quarterly Trading Report 2025 Q3
Earlier from NanoEcho
- NANECH: Clinical milestones reached, losses narrowed, and first revenues expected soon
- NANECH: Clinical milestone achieved and financial base strengthened for rectal cancer diagnostics
- NANECH: Clinical progress, new financing, and IPO recognition mark NanoEcho's pivotal year
- NANECH: Strong equity and clinical progress position NanoEcho for future commercialization
- NANECH: Product development finalized, ISO certified, and clinical phase initiated after successful financing
Later from NanoEcho
- Nanoecho Adjusts Diagnostic System UI After Study Feedback
- Nanoecho Gets SEK 0.3 Mln Funding From Vinnova
- Nanoecho Q3 Net Sales Amounted To SEK 488.000
- NanoEcho AB (publ) receives observation status
- NanoEcho Gets Approval For NEP-01 In Proof Of Concept Study
Follow NanoEcho into a list and get an email when it puts out news.
Follow NanoEcho